{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T17:13:16Z","timestamp":1794503596643,"version":"4.9.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82405037"],"award-info":[{"award-number":["82405037"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.biomaterials.2026.124215","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T16:34:19Z","timestamp":1775666059000},"page":"124215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A biomimetic arsenic-based nanozyme enhances dual epigenetic regulation to improve the efficacy of immunotherapy for acute myeloid leukaemia"],"prefix":"10.1016","volume":"333","author":[{"given":"Aqian","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hulinyue","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinzhu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxv","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1974-044X","authenticated-orcid":false,"given":"Jian","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.biomaterials.2026.124215_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2016.50","article-title":"Acute myeloid leukemia: a comprehensive review and 2016 update","volume":"6","author":"De Kouchkovsky","year":"2016","journal-title":"Blood Cancer J."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124215_bib2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41568-019-0230-9","article-title":"The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML","volume":"20","author":"Vetrie","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124215_bib3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41568-020-0260-3","article-title":"Dysregulated haematopoietic stem cell behaviour in myeloid leukaemogenesis","volume":"20","author":"Yamashita","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124215_bib4","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41571-020-0410-2","article-title":"Clinical development and potential of photothermal and photodynamic therapies for cancer","volume":"17","author":"Li","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124215_bib5","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1172\/JCI129204","article-title":"Immune escape and immunotherapy of acute myeloid leukemia","volume":"130","author":"Vago","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biomaterials.2026.124215_bib6","article-title":"Advances in acute myeloid leukemia","volume":"375","author":"Newell","year":"2021","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124215_bib7","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1056\/NEJMra1805035","article-title":"Epigenetic therapies for cancer","volume":"383","author":"Bates","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124215_bib8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41576-018-0074-2","article-title":"Clinical epigenetics: seizing opportunities for translation","volume":"20","author":"Berdasco","year":"2019","journal-title":"Nat. Rev. Genet."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124215_bib9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41375-020-01069-1","article-title":"New strategies to treat AML: novel insights into AML survival pathways and combination therapies","volume":"35","author":"Nair","year":"2021","journal-title":"Leukemia"},{"issue":"18","key":"10.1016\/j.biomaterials.2026.124215_bib10","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1182\/blood-2009-09-240978","article-title":"Study Alliance Leukemia, profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia","volume":"116","author":"M\u00fcller-Tidow","year":"2010","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124215_bib11","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1158\/2159-8290.CD-23-0876","article-title":"Condensate-Promoting ENL mutation drives tumorigenesis in vivo through dynamic regulation of histone modifications and gene expression","volume":"14","author":"Liu","year":"2024","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124215_bib12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.trecan.2015.12.006","article-title":"The impact of DNA methylation in hematopoietic malignancies","volume":"2","author":"Guillamot","year":"2016","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124215_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/leu.2013.242","article-title":"Origins of aberrant DNA methylation in acute myeloid leukemia","volume":"28","author":"Schoofs","year":"2014","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124215_bib14","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ccr.2012.03.045","article-title":"DNA methylation screening identifies driver epigenetic events of cancer cell survival","volume":"21","author":"De Carvalho","year":"2012","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124215_bib15","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41375-023-01810-6","article-title":"The histone demethylase KDM5C functions as a tumor suppressor in AML by repression of bivalently marked immature genes","volume":"37","author":"Trempenau","year":"2023","journal-title":"Leukemia"},{"issue":"35","key":"10.1016\/j.biomaterials.2026.124215_bib16","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.1038\/sj.onc.1205699","article-title":"5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy","volume":"21","author":"Christman","year":"2002","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124215_bib17","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1182\/blood-2003-03-0687","article-title":"Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies","volume":"103","author":"Issa","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124215_bib18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41392-023-01342-6","article-title":"Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124215_bib19","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/neuonc\/nos308","article-title":"Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome","volume":"15","author":"Lalezari","year":"2013","journal-title":"Neuro Oncol."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124215_bib20","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1039\/D3TB02819D","article-title":"Nanozymes: a new approach for leukemia therapy","volume":"12","author":"Wang","year":"2024","journal-title":"J. Mater. Chem. B"},{"issue":"14","key":"10.1016\/j.biomaterials.2026.124215_bib21","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1039\/C8CS00718G","article-title":"Nanozyme: new horizons for responsive biomedical applications","volume":"48","author":"Jiang","year":"2019","journal-title":"Chem. Soc. Rev."},{"issue":"23","key":"10.1016\/j.biomaterials.2026.124215_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202302335","article-title":"Ultra-Small high-entropy alloy nanoparticles: efficient nanozyme for enhancing tumor photothermal therapy","volume":"35","author":"Ai","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124215_bib23","first-page":"117","article-title":"High-performance SOD mimetic enzyme au@ce for arresting cell cycle and proliferation of acute myeloid leukemia","volume":"10","author":"Sun","year":"2021","journal-title":"Bioact. Mater."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124215_bib24","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1021\/nn300291r","article-title":"Dual enzyme-like activities of iron oxide nanoparticles and their implication for diminishing cytotoxicity","volume":"6","author":"Chen","year":"2012","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124215_bib25","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1038\/s41467-022-33098-y","article-title":"Depletable peroxidase-like activity of FeO nanozymes accompanied with separate migration of electrons and iron ions","volume":"13","author":"Dong","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124215_bib26","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1038\/s41467-025-57376-7","article-title":"In situ valence-transited arsenic nanosheets for multi-modal therapy of colorectal cancer","volume":"16","author":"Zheng","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124215_bib27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2217\/epi.09.45","article-title":"Effects of arsenic exposure on DNA methylation and epigenetic gene regulation","volume":"2","author":"Reichard","year":"2010","journal-title":"Epigenomics"},{"issue":"25","key":"10.1016\/j.biomaterials.2026.124215_bib28","doi-asserted-by":"crossref","first-page":"7088","DOI":"10.1016\/j.biomaterials.2014.04.072","article-title":"Polymeric micelles for GSH-triggered delivery of arsenic species to cancer cells","volume":"35","author":"Zhang","year":"2014","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124215_bib29","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1038\/s41375-025-02663-x","article-title":"Comparison of induction with arsenic trioxide or chemotherapy in a real-world cohort of patients with high-risk acute promyelocytic leukemia","volume":"39","author":"Lebon","year":"2025","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124215_bib30","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.leukres.2004.01.011","article-title":"The potential of arsenic trioxide in the treatment of malignant disease: past, present, and future","volume":"28","author":"Evens","year":"2004","journal-title":"Leuk. Res."},{"key":"10.1016\/j.biomaterials.2026.124215_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1634\/theoncologist.6-suppl_2-1","article-title":"Introduction: the history of arsenic trioxide in cancer therapy","volume":"2","author":"Antman","year":"2001","journal-title":"Oncologist"},{"key":"10.1016\/j.biomaterials.2026.124215_bib32","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12935-015-0269-y","article-title":"Arsenic trioxide reduces chemo-resistance to 5-fluorouracil and cisplatin in HBx-HepG2 cells via complex mechanisms","volume":"15","author":"Yu","year":"2015","journal-title":"Cancer Cell Int."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124215_bib33","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s12094-019-02054-6","article-title":"A candidate for lung cancer treatment: arsenic trioxide","volume":"21","author":"Huang","year":"2019","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.biomaterials.2026.124215_bib34","article-title":"Engineered tumor microvesicles modified by SP94 peptide for arsenic trioxide targeting drug delivery in liver cancer therapy","volume":"155","author":"Raza","year":"2023","journal-title":"Biomater. Adv."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124215_bib35","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12951-022-01386-w","article-title":"Correction to: augmented EPR effect post IRFA to enhance the therapeutic efficacy of arsenic loaded ZIF-8 nanoparticles on residual HCC progression","volume":"20","author":"Chen","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"23","key":"10.1016\/j.biomaterials.2026.124215_bib36","doi-asserted-by":"crossref","first-page":"23829","DOI":"10.1021\/acsnano.3c07885","article-title":"Magnetic metal-organic framework-based nanozyme with platelet membrane coating as a synergistic programmed cell death protein 1 inhibitor against hepatocellular carcinoma","volume":"17","author":"Guo","year":"2023","journal-title":"ACS Nano"},{"issue":"57","key":"10.1016\/j.biomaterials.2026.124215_bib37","doi-asserted-by":"crossref","first-page":"13189","DOI":"10.1002\/chem.201902599","article-title":"Zeolitic imidazolate Framework-8 as pH-Sensitive nanocarrier for \"Arsenic Trioxide\" drug delivery","volume":"25","author":"Ettlinger","year":"2019","journal-title":"Chemistry"},{"issue":"12","key":"10.1016\/j.biomaterials.2026.124215_bib38","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1038\/leu.2009.175","article-title":"Contribution of bone microenvironment to leukemogenesis and leukemia progression","volume":"23","author":"Ayala","year":"2009","journal-title":"Leukemia"},{"issue":"23","key":"10.1016\/j.biomaterials.2026.124215_bib39","doi-asserted-by":"crossref","first-page":"12971","DOI":"10.1002\/anie.202101924","article-title":"Single-Atom Pd nanozyme for ferroptosis-boosted mild-temperature photothermal therapy","volume":"60","author":"Chang","year":"2021","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"9","key":"10.1016\/j.biomaterials.2026.124215_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202208512","article-title":"Single-Atom nanozyme with asymmetric electron distribution for tumor catalytic therapy by disrupting tumor Redox and energy metabolism homeostasis","volume":"35","author":"Liu","year":"2023","journal-title":"Adv. Mater."},{"issue":"16","key":"10.1016\/j.biomaterials.2026.124215_bib41","doi-asserted-by":"crossref","first-page":"8965","DOI":"10.1021\/jacs.2c13689","article-title":"Multi-enzyme Co-expressed dual-atom nanozymes induce Cascade immunogenic ferroptosis via activating Interferon-\u03b3 and targeting arachidonic acid metabolism","volume":"145","author":"Liu","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"49","key":"10.1016\/j.biomaterials.2026.124215_bib42","doi-asserted-by":"crossref","first-page":"20927","DOI":"10.1021\/jacs.1c09741","article-title":"Phenylboronic acid modification augments the lysosome escape and antitumor efficacy of a cylindrical polymer brush-based prodrug","volume":"143","author":"Wang","year":"2021","journal-title":"J. Am. Chem. Soc."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124215_bib43","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41551-024-01178-7","article-title":"Severely polarized extracellular acidity around tumour cells","volume":"8","author":"Feng","year":"2024","journal-title":"Nat. Biomed. Eng."},{"issue":"10","key":"10.1016\/j.biomaterials.2026.124215_bib44","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1038\/s41375-021-01388-x","article-title":"Lysosomes in acute myeloid leukemia: potential therapeutic targets","volume":"35","author":"Rafiq","year":"2021","journal-title":"Leukemia"},{"issue":"46","key":"10.1016\/j.biomaterials.2026.124215_bib45","doi-asserted-by":"crossref","first-page":"32235","DOI":"10.1021\/acsnano.4c13087","article-title":"Photothermally reinforced nanozyme remodeling tumor microenvironment of Redox and metabolic homeostasis to enhance ferroptosis in tumor therapy","volume":"18","author":"Qin","year":"2024","journal-title":"ACS Nano"},{"issue":"15","key":"10.1016\/j.biomaterials.2026.124215_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202107088","article-title":"A bioinspired five-coordinated single-atom iron nanozyme for tumor catalytic therapy","volume":"34","author":"Xu","year":"2022","journal-title":"Adv. Mater."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124215_bib47","article-title":"Tumor microenvironment-driven structural transformation of vanadium-based MXenzymes to amplify oxidative stress for multimodal tumor therapy","volume":"12","author":"Zhu","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124215_bib48","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/s12951-025-03453-4","article-title":"Tumor microenvironment responsive Mn-based nanozyme activate cGAS-STING pathway combined with metabolic interference for enhanced anti-tumor therapy","volume":"23","author":"Wen","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124215_bib49","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12943-025-02380-0","article-title":"Demystifying the cGAS-STING pathway: precision regulation in the tumor immune microenvironment","volume":"24","author":"Wang","year":"2025","journal-title":"Mol. Cancer"},{"issue":"26","key":"10.1016\/j.biomaterials.2026.124215_bib50","doi-asserted-by":"crossref","first-page":"24034","DOI":"10.1021\/acsnano.5c06592","article-title":"Multienzymatic hybrid metalloenzymes triggering Cascade reactions-regulated tumor redox homeostasis and immunosuppressive microenvironment for catalytic immunotherapy","volume":"19","author":"Sun","year":"2025","journal-title":"ACS Nano"},{"issue":"45","key":"10.1016\/j.biomaterials.2026.124215_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202409618","article-title":"Ultrasmall enzyodynamic PANoptosis nano-inducers for ultrasound-amplified hepatocellular carcinoma therapy and lung metastasis inhibition","volume":"36","author":"Wei","year":"2024","journal-title":"Adv. Mater."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124215_bib52","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41419-023-05878-x","article-title":"Epigenetically modified AP-2\u03b1 by DNA methyltransferase facilitates glioma immune evasion by upregulating PD-L1 expression","volume":"14","author":"Long","year":"2023","journal-title":"Cell Death Dis."},{"issue":"15","key":"10.1016\/j.biomaterials.2026.124215_bib53","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2013598118","article-title":"Epigenetic reprogramming of tumor cell-intrinsic STING function sculpts antigenicity and T cell recognition of melanoma","volume":"118","author":"Falahat","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biomaterials.2026.124215_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202508681","article-title":"Breaking apoptosis-induced immune silence: Ultrasound-activated nano-oncolytic therapy reinvigorates antitumor immunity","author":"Fang","year":"2025","journal-title":"Adv. Mater."},{"issue":"25","key":"10.1016\/j.biomaterials.2026.124215_bib55","first-page":"74","article-title":"Metabolic regulation of cGAS-STING signaling in the tumor microenvironment: dual immune roles and therapeutic implications","volume":"S1359\u20136101","author":"Wu","year":"2025","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124215_bib56","doi-asserted-by":"crossref","first-page":"7930","DOI":"10.1038\/s41467-024-52170-3","article-title":"Targeting PRMT3 impairs methylation and oligomerization of HSP60 to boost anti-tumor immunity by activating cGAS\/STING signaling","volume":"15","author":"Shi","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124215_bib57","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1038\/s41467-023-38443-3","article-title":"PRMT1 mediated methylation of cGAS suppresses anti-tumor immunity","volume":"14","author":"Liu","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124215_bib58","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41392-020-00361-x","article-title":"Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy","volume":"5","author":"Carter","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124215_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2017.8","article-title":"The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells","volume":"7","author":"Nishida","year":"2017","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.biomaterials.2026.124215_bib60","article-title":"Multipath ROS storm and immune activation via sulfur vacancy-optimized ZnIn2S4 nanosheets for piezocatalytic tumor therapy","author":"Yang","year":"2025","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124215_bib61","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1038\/s41467-025-60448-3","article-title":"Neoantigens combined with in situ cancer vaccination induce personalized immunity and reshape the tumor microenvironment","volume":"16","author":"Feng","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124215_bib62","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13046-025-03377-9","article-title":"Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy","volume":"44","author":"Yang","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124215_bib63","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010950","article-title":"Reprogramming tumor-associated macrophages using STING or TLR agonists: a promising strategy to enhance immunotherapy in hormone-dependent cancers","volume":"13","author":"Sacristan Santos","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124215_bib64","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s40164-025-00680-1","article-title":"Prophylactic infusion of allogeneic double-negative T cells as immune modulators to prevent relapse in high-risk AML patients post-Allo-HSCT: a phase I trial","volume":"14","author":"Sun","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.biomaterials.2026.124215_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118287","article-title":"Bone marrow tumor microenvironment profiling predicts distinct immunosuppressive phenotypes and immunotherapy potential in AML patients","volume":"189","author":"da Cruz","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biomaterials.2026.124215_bib66","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jes.2016.06.005","article-title":"Role of complex organic arsenicals in food in aggregate exposure to arsenic","volume":"49","author":"Thomas","year":"2016","journal-title":"J. Environ. Sci. (China)"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226002395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226002395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:34:02Z","timestamp":1793946842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226002395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":66,"alternative-id":["S0142961226002395"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124215","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A biomimetic arsenic-based nanozyme enhances dual epigenetic regulation to improve the efficacy of immunotherapy for acute myeloid leukaemia","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124215","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124215"}}